Paolo Michieli

Company: AgomAb

Job title: Chief Scientific Officer

Seminars:

Panel Discussion: Lessons Learnt & Most Promising Avenues for Drug Discovery 12:30 pm

• Interrogating heterogeneous disease pathologies to illuminate opportunities for therapeutic intervention • Learning from setbacks in IPF & NASH to inform future pipeline strategyRead more

day: Day Two

Separating Mechanisms of Wound Healing & Chronic Fibrosis to Define More Specific Therapeutic Targets for Drug Development Success 8:30 am

• Understanding the biomarkers that reflect fibrosis vs inflammation or biomarkers that represent interplay between the two from translational perspective • Overcoming the challenges to standardising, measuring and quantifying healthy wound repair response in humans • Reviewing studies differentiating between kind of progressive fibrosis and wound healing in human/clinical trialsRead more

day: Day Two